MedPath

The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation

Not Applicable
Completed
Conditions
Heart Disease
Interventions
Procedure: Forearm Venous Occlusion Plethysmography
Registration Number
NCT00745446
Lead Sponsor
University of Edinburgh
Brief Summary

The purpose of this study is to determine whether a retrofit particle trap can reduce the adverse vascular responses to diesel exhaust inhalation

Detailed Description

18 subjects healthy male volunteers will be recruited at Umeå University. In a randomised, double blind 3 way crossover trial, subjects will be exposed to filtered air, diesel exhaust (300mcg/m3) or filtered diesel exhaust for 1 hour during intermittent exercise.

2 hours following the exposure, thrombogenicity will be assessed using the Badimon chamber - an ex-vivo model of thrombosis formed under constant flow conditions.

Forearm blood flow in response to infused intra-brachial vasodilators will be measured using venous occlusion plethysmography 6 hours after the exposure.

Arterial stiffness will be measured using peripheral arterial applanation tonometry in the hour post-exposure.

Blood samples will be collected at timepoints over the 24 hours after exposure.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
18
Inclusion Criteria
  • Healthy male volunteers
Exclusion Criteria
  • Intercurrent illness
  • Smoking
  • Significant occupational exposure to air pollution
  • Regular medication usage

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1Forearm Venous Occlusion Plethysmography1 hour exposure to filtered air
2Forearm Venous Occlusion Plethysmography1 hour exposure to diesel exhaust (300mcg/m3)
3Forearm Venous Occlusion Plethysmography1 hour exposure to filtered diesel exhaust
Primary Outcome Measures
NameTimeMethod
Forearm blood flow in response to infused intra-arterial vasodilators6 hours post-exposure
Secondary Outcome Measures
NameTimeMethod
Arterial stiffness measured by applanation tonometryIn the 1 hour following exposure
Thrombogenicity measured using the Badimon chamber - an ex-vivo model of thrombosis under conditions of continuous flow2 hours after the exposure
Exhaled nitric oxide - a marker of pulmonary inflammation1 hour & 6 hours after exposure
Endogenous fibrinolytic capacity - measured as net release of t-PA in response to infused bradykinin6 hours after exposure
Biochemical markers of systemic inflammationBaseline, 2, 6 & 24 hours

Trial Locations

Locations (1)

Umeå University

🇸🇪

Umeå, Västerbottens, Sweden

© Copyright 2025. All Rights Reserved by MedPath